Mark Pruzanski
2020
Compensation breakdown
| Non-Equity Incentive Plan | $531,995 |
|---|---|
| Option Awards | $1,015,996 |
| Salary | $757,850 |
| Stock Awards | $4,113,504 |
| Other | $7,660 |
| Total | $6,427,005 |
Pruzanski received $4.1M in stock awards, accounting for 64% of the total pay in 2020.
Pruzanski also received $532K in non-equity incentive plan, $1M in option awards, $757.9K in salary and $7.7K in other compensation.
Rankings
In 2020, Mark Pruzanski's compensation ranked 1,583rd out of 13,090 executives tracked by ExecPay. In other words, Pruzanski earned more than 87.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,583 out of 13,090 | 88th |
Division Manufacturing | 592 out of 5,621 | 90th |
Major group Chemicals And Allied Products | 213 out of 2,254 | 91st |
Industry group Drugs | 177 out of 1,954 | 91st |
Industry Pharmaceutical Preparations | 122 out of 1,459 | 92nd |
Pay ratio
| Mark Pruzanski's Pay | $6,427,005 |
|---|---|
| Median Employee's Pay | $267,493 |
| Pay Ratio | 24to 1 |
In 2020, the annual total compensation of Mark Pruzanski was $6,427,005.
The annual total compensation of the median employee at Intercept Pharmaceuticals was $267,493.
The ratio of Mark Pruzanski's pay to the pay of median employee was therefore 24 to one.
Pruzanski's colleagues
We found six more compensation records of executives who worked with Mark Pruzanski at Intercept Pharmaceuticals in 2020.
2020
Jerome Durso
Intercept Pharmaceuticals
Chief Operating Officer
2020
Sandip Kapadia
Intercept Pharmaceuticals
Chief Financial Officer
2020
Richard Kim
Intercept Pharmaceuticals
Former President, U.S. Commercial & Strategic Marketing
2020
Lisa Bright
Intercept Pharmaceuticals
Former President, International
2020
Ryan Sullivan
Intercept Pharmaceuticals
General Counsel
2020
Christian MAS
Intercept Pharmaceuticals